Tegoprazan
CAS 942195-55-3
Overview
Tegoprazan is a novel potassium-competitive acid blocker (P-CAB) used to treat gastroesophageal reflux disease (GERD), erosive esophagitis, and gastric ulcers
Anant Labs manufacture and furnish high quality Tegoprazan impurities for global markets. Our Tegoprazan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
New Cat. No.ANTPRD7843
Old Cat. No.ANT-TGP-001
CAS942195-55-3
Mol. FormulaC20H19F2N3O3
Mol. Weight387.39 g/mol
IUPAC7-[[(4S)-5,7-difluoro-3,4-dihydro-2H-chromen-4-yl]oxy]-N,N,2-trimethyl-3H-benzimidazole-5-carboxamide
SMILESO=C(C1=CC(O[C@H]2CCOC3=C2C(F)=CC(F)=C3)=C4NC(C)=NC4=C1)N(C)C
InChIInChI=1S/C20H19F2N3O3/c1-10-23-14-6-11(20(26)25(2)3)7-17(19(14)24-10)28-15-4-5-27-16-9-12(21)8-13(22)18(15)16/h6-9,15H,4-5H2,1-3H3,(H,23,24)/t15-/m0/s1
InChI KeyCLIQCDHNPDMGSL-HNNXBMFYSA-N
Synonyms
(S)-7-((5,7-Difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-5-carboxamideTegoprazan942195-55-3CJ-12420W017G7IF4SK-CABLXI-150287-[[(4S)-5,7-difluoro-3,4-dihydro-2H-chromen-4-yl]oxy]-N,N,2-trimethyl-3H-benzimidazole-5-carboxamide(S)-4-((5,7-Difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide(S)-4-((5,7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo(d)imidazole-6-carboxamide


